Áñ°Üã±â ȸ¿ø°¡ÀԷα×ÀÎ

¸¶ÄÉÆÿµ¾÷
Æ®·»µå    
¸¶ÄÉÆÃ&¼¼ÀÏÁî    
¸®Å©·çÆà   
È°µ¿°ü¸®    
Á¡Æ÷¿î¿µ    
¿µ¾÷½ºÅ³    
Àθưü¸®    
¼¼ÀÏÁų    
±Û·Î¹úºñÁî´Ï½º    
±ÝÀ¶ÀçÅ×Å©
À繫¼³°è    
ÀºÅð¼³°è    
º¯¾×º¸Çè    
Áõ±ÇÆݵ堠  
PB    
º¸Çè»óÇ°    
°æ¿µ,°æÁ¦Àü·«
º¯È­Çõ½Å    
Áö½Ä°æ¿µ    
6½Ã±×¸¶    
ºñÀü&¹Ì¼Ç    
±âȹ·Â    
°Å½Ã°æÁ¦    
âÁ¶,âÀÇ,    
Á¶Á÷±³À°Àλç
HRD    
Á¶Á÷°ü¸®    
Àλç°ü¸®    
¼º°ú°ü¸®    
ȸÀǽºÅ³    
°­»ç¾ç¼º    
¸éÁ¢°ü ±³À°,¸éÁ¢¿ä·É    
Á¶Á÷È°¼ºÈ­    
µ¿±âºÎ¿©&¼º°øó¼¼
µ¿±âºÎ¿©    
¼º°øó¼¼    
¼º°ø½ÅÈ­    
¸®´õ½Ê&Ä¿¹Â´ÏÄÉÀ̼Ç
¸®´õ½Ê    
Ä¿¹Â´ÏÄÉÀ̼Ǡ   
°¥µî°ü¸®    
¹®Á¦ÇØ°á    
Çù»ó½ºÅ³    
ÇÁ¸®Á¨Å×À̼Ǡ   
CS
BIZ¸Å³Ê    
CS    
¼­ºñ½º±âȹ    
¼­ºñ½º¸¶ÄÉÆà   
CRM    
¼Õº¸ ½Ç¹«½ºÅ³    
À̹ÌÁö¸ÞÀÌÅ·    
ÀϹݱ³¾ç
¹®ÇР   
À½¾Ç    
¹Ì¼ú    
½ºÆ÷Ã÷    
¹®È­¿¹¼ú    
¿ª»ç    
°úÇС¤±â¼ú    
»ç»ó¡¤Ã¶ÇР   
µ¶¼­¹ý    
°Ç°­&·¹Å©¸®¿¡À̼Ç
°Ç°­    
·¹Å©¸®¿¡À̼Ǡ   
À¯¸Ó¡¤È­¼ú    
±âŸƯ°­
¾ÈÀü¡¤º¸°Ç    
Á¤½Å¼Ò¾ç    
°æ¿µ¡¤°æÁ¦ Ư°­    
Á÷¾÷,Áø·Î±³À°    
ÆÀºôµù    
Èú¸µ    
µµÀü, ¿­Á¤    
½ºÅ¸
½ºÅ¸ Ư°­    

°í°´´ÔÀÇ ¸»¾¸À» Ç×»ó
±Í±â¿ï¿© µè°Ú½À´Ï´Ù.

´ëÇ¥ÀüÈ­ :
02-6263-0487

À̸ÞÀÏ : Mail to admin

Àüü°­»ç

ÀÌ´ÞÀÇ Ãßõ°­»ç

½Å±Ôµî·Ï°­»ç

Àüü°­»ç

ÇöÀçÀ§Ä¡ : Ȩ > °­»ç¼Ò°³ > Àüü°­»ç



°­»ç Á¤º¸ »ó¼¼º¸±â
°­»ç¸í : Çѱ¤Çù
°­ÀÇÁÖÁ¦ :
ÇöÁ÷(ÇöÁ÷Àå¸í) : ¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ¼ÒÈ­±â³»°ú ±³¼ö
Àü¹®ºÐ¾ß : °úÇС¤±â¼ú/°Ç°­/
ÇзÂ
¿¬¼¼´ëÇб³ ÀÇÇÐ Çлç
°æ·Â
* ±³À° ¹× ÀÓ»ó °æ·Â

1986.-1995. ¿¬¼¼ÀÇ´ë ³»°ú ÀüÀÓ°­»ç, Á¶±³¼ö
1990.-1992. ¹Ì±¹ Baylor ÀÇ´ë Research associate
1995.-2000. ¿¬¼¼ÀÇ´ë ³»°ú ºÎ±³¼ö
2000.-ÇöÀç ¿¬¼¼ÀÇ´ë ³»°ú ±³¼ö


* Çмú°ü·Ã°æ·Â

ÇöÀç ´ëÇÑÀÇÇÐÇùȸ/´ëÇѳ»°úÇÐȸ,
´ëÇѼÒÈ­±â³»½Ã°æÇÐȸÀÇ Æò»ýȸ¿ø
´ëÇѼÒÈ­±âÇÐȸ/´ëÇÑ°£ÇÐȸ ÆòÀÇ¿ø
¹Ì±¹°£ÇÐȸ Åë½Åȸ¿ø.
´ëÇÑ°£ÇÐȸ Ãѹ«/³»°úÀü¹®ÀÇ
¼ÒÈ­±âºÐ°ú ¹× ¼ÒÈ­±â³»½Ã°æ Àü¹®ÀÇ
´ëÇÑ°£¾Ï¿¬±¸È¸ °¨»ç
KBS ÀÇ·áÀÚ¹®À§¿ø
¾ÏÁ¶±â°ËÁø»ç¾÷ Áö¿øÆò°¡´Ü À§¿ø
±âŸ
* ³í¹®

»ç¿°È­Åº¼Ò·Î ±Þ¼º °£¼Õ»óÀÌ À¯¹ßµÈ ÈòÁã¿¡¼­ Ç÷û ¹× °£Á¶Á÷ÀÇ Transforming Growth Factor-¥â©ûÀÇ º¯È­¿Í ºñŸ¹Î EÀÇ È¿°ú
´ëÇÑ°£ÇÐȸÁö 6(2) : 147-155 , 2000

40¼¼ ÀÌÇÏ¿¡¼­ ¹ß»ýÇÑ ¿ø¹ß¼º °£¾ÏÀÇ ÀÓ»ó»ó
´ëÇѼÒÈ­±âÇÐȸÁö 35(2) : 196-202 , 2000

º´»ç¿ë Áø´Ü¼­ ¹ß±ÞÀ» À§ÇØ º¹°­°æ°Ë»ç¿¡¼­ °£Á¶Á÷°Ë»ç¸¦ ½ÃÇàÇÑ ÀþÀº ¼ºÀÎ ³²ÀÚÀÇ °£Ä§»ý°Ë ¼Ò°ß: »õ·Î¿î ¸¸¼º°£¿°º´¸®ºÐ·ù¸¦ ±âÁØÀ¸·Î
´ëÇѼÒÈ­±âÇÐȸÁö 36(2) : 224-234 , 2000

°æ°£µ¿¸Æ Ç×¾Ï »öÀü¼ú ÈÄ Ä¡·á ½ÇÆÐÇÑ ¿ø¹ß¼º °£¾Ï¿¡¼­ ±¹¼Ò ¹æ»ç¼± ¿ä¹ýÀÇ ±¸Á¦ Ä¡·á È¿°ú
´ëÇѾÏÇÐȸ 32(1) : 220-228 , 2000

Combined transcatheter arterial chemoembolization and local radiotherapy of unresectable heaptocellular carcinoma
International Journal Of Radiation Oncology Biolog 43 (2) : 393-397 , 2000

Local radiotherapy for unresectable hepatocellular carcinoma patients who failed with transcatheter arterial chemoembolization
International Journal Of Radiation Oncology Biolog 47(5) : 1331-1335 , 2000

°£¾Ï °íÀ§Ç豺ÀÇ Á¶±âÁø´ÜÀ» À§ÇÑ ¼±º°°Ë»ç(Screening) ¹æ¾È ¼ö¸³ ¹× È¿°ú Æò°¡ ¿¬±¸
Journal Of Korean Cancer Association 32(6) : 1084-1092 , 2000

¸¸¼º BÇü °£¿°°ú ½ÅÀåÁúȯÀÇ Á¶Á÷ÇÐÀû »ó°ü°ü°è
´ëÇÑ°£ÇÐȸÁö 7(4) : 413-422 , 2001

Æó·Å ¹ß»ý ÈÄ ÀÚ¿¬ ±«»çµÈ °£¼¼Æ÷¾ÏÁ¾ 1¿¹
´ëÇÑ°£ÇÐȸÁö 7(3) : 330-335 , 2001

¿ø¹ß¼º °£¾ÏȯÀÚÀÇ °£¿° ¹ÙÀÌ·¯½º °¨¿°À¯Çü¿¡ µû¸¥ ÀÓ»ó¾ç»ó ¹× ¿¹ÈÄ
´ëÇѳ»°úÇÐȸÁö 60(1) : 22-31 , 2001

¿ø¹ß¼º °£¾ÏÀÇ ±¹¼Ò ¹æ»ç¼±Ä¡·á ½Ã ¼±·®¹ÝÀÀ °ü°è
´ëÇѹæ»ç¼±Á¾¾çÇÐȸÁö 19(2) : 118-126 , 2001

An ischemic skin lesion after chemoembolization of the right internal mammary artery in a patient with hepatocellular carcinoma
Yonsei Medical Journal 42(1) : 137-141 , 2001

Oxidative stress effect on the activation of hepatic stellate cells
Yonsei Medical Journal 42(1) : 1-8 , 2001

ÀýÁ¦ ºÒ°¡´ÉÇÑ ¿ø¹ß¼º °£¾ÏÀÇ ÀÔüÁ¶Çü ¹æ»ç¼±Ä¡·áÀÇ Ãʱâ ÀÓ»ó °á°ú
´ëÇѹæ»ç¼±Á¾¾çÇÐȸÁö 20-2 : 123-129 , 2002

°£¼¼Æ÷¾Ï¿¡¼­ À¯·¡ÇÑ °ñÀüÀÌÀÇ ¹æ»ç¼±Ä¡·á
´ëÇÑ°£ÇÐȸÁö 8-3 : 304-311 , 2002

ÁøÇ༺ °£¼¼Æ÷¾Ï¿¡¼­ÀÇ °æÇÇÀû °£µ¿¸ÆÆ÷Æ®¼³Ä¡¼úÀ» ÀÌ¿ëÇÑ È­Çпä¹ý°ú ü¿Ü ¹æ»ç¼± Á¶»çÀÇ º´¿ë¿ä¹ý
´ëÇѹæ»ç¼±ÀÇÇÐȸÁö 47 : 583-590 , 2002

DOSE-RESPONSE RELATIONSHIP IN LOCAL RADIOTHERAPY FOR HEPATOCELLULAR CARCINOMA
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOG 54-1 : 150-155 , 2002

Factors Predictive of Response to Interferon-a Therapy in Hepatitis C Virus Type 1b Infection
JOURNAL OF MEDICAL VIROLOGY 66 : 481-487 , 2002

¹ÙÀÌ·¯½º¼º °£¿°ÀÇ ºÐÀÚ»ý¹°ÇÐÀû ¹× Ç÷ûÇÐÀû Áø´Ü
MEDICAL POSTGRADUATES 30-2 : , 2002

Immunogenetics of hepatitis B virus infection
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 17 : 329-332 , 2002

Treatment of non-resectable hepatocellular carcinoma
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 17 : 424-427 , 2002

¸¸¼º BÇü °£¿°¿¡¼­ HLA A2/core 18-27 tetramer º¹ÇÕü¸¦ ÀÌ¿ëÇÑ BÇü °£¿°¹ÙÀÌ·¯½º ƯÀÌ CD8+ ¸²ÇÁ±¸ÀÇ ºÐ¼®
´ëÇÑ°£ÇÐȸÁö 8(2) : 139-148 , 2002

¸¸¼º BÇü °£¿°¿¡¼­ BÇü °£¿° ¹ÙÀÌ·¯½º ƯÀÌ CD8+ ¸²ÇÁ±¸ÀÇ Chemokine ¼ö¿ëü ¹ß°ß
´ëÇÑ°£ÇÐȸÁö 8(4) : 363-370 , 2002

°£°æº¯ ȯÀÚ¿¡¼­ ±Þ¼º½ÅºÎÀüÀÇ À§ÇèÀÎÀÚ
´ëÇѽÅÀåÇÐȸÁö 22-5 : 552-558 , 2003

°£¾ÏÀÇ Á¶±â ¹ß°ßÀ» À§ÇÑ °ËÁø
´ëÇѼÒÈ­±âÇÐȸÁö : 119-125 , 2003

Â÷¼¼´ë BÇü °£¿° Ç×¹ÙÀÌ·¯½ºÁ¦ÀÇ Àü¸Á
´ëÇÑ°£ÇÐȸÁö 9(s2) : 20-26 , 2003

Apoptosis of hepatic stellatte cells in carbon tetrachloride induced acute liver injury of the rat : analysis of isolated hepatic stellate cells
JOURNAL OF HEPATOLOGY 39 : 960-966 , 2003

CLINICAL RESULTS AND PROGNOSTIC FACTORS IN RADITHERAPY FOR UNRESECTABLE HEPATOCELLULAR CARCINOMA : A RETROSPECTIVE STUDY OF 158 PATIENTS
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 55(2) : 329-336 , 2003

Clinical results of 3-dimensional conformal radiotherapy combined with transarterial chemoembolization for hepatocellular carcinoma in the cirrhotic patients
HEPATOLOGY RESEARCH : 1-6 , 2003

Evolution of Hepatitis B Birus Sequence from a Liver Transplant Recipient With Rapid breakthrough Despite Hepatitis B Immune Globulin Prophylaxis and Lamivudine Therapy
JOURNAL OF MEDICAL VIROLOGY 71 : 367-375 , 2003

Lethal hepatic injury by combined treatment of radiation plus chemotherapy in rats with thioacetamide-induced liver cirrhosis
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 57(1) : 282-288 , 2003

Telomere shortening and telomerase reactivation in dysplastic nodules of human hepatocarcinogenesis
JOURNAL OF HEPATOLOGY 39(5) : 786-792 , 2003

Treatment of non-resctable hepatocellular carcinoma
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 17 : 424-427 , 2003

Çѱ¹Àο¡¼­ Àü°Ý¼º °£ºÎÀüÀÇ ÀÓ»óÀû Ư¡ ¹× ¿¹ÈÄ ÀÎÀÚ
´ëÇÑ°£ÇÐȸÁö 10-4 : 298-307 , 2004

¸»µðÅäÇÁ Áú·® ºÐ¼®À» ÀÌ¿ëÇÑ Çѱ¹ÀÎÀÇ BÇü°£¿° ¹ÙÀÌ·¯½º À¯ÀüÀÚÇü ¹× ÀÓ»óÀû ÀÇÀÇ¿¡ ´ëÇÑ ÀçÆò°¡
´ëÇÑ°£ÇÐȸÁö 10-4 : 260-270 , 2004

°£¾Ï Á¶±â Áø´ÜÀ» À§ÇÑ °³Àκ° °£¾Ï¹ß»ý ¿¹Ãø¸ðÇüÀÇ À¯¿ë¼º
´ëÇѳ»°úÇÐȸÁö 67-1 : 7-14 , 2004

Long-term clinical Outcome of Large Volume paracentesis in patients with spontaneous Bacteria peritonitis: Result of a Randomized Prospective study
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY : °ÔÀ翹Á¤ , 2004

Àڹ߼º ¼¼±Õ¼º º¹¸·¿° ȯÀÚ¿¡¼­ Ä¡·á °æ°ú¿¡ µû¸¥ º¹¼ö Nitric oxide(NO)ÀÇ º¯È­
´ëÇÑ°£ÇÐȸÁö 10-3 : 207-215 , 2004

Treatment Outcome of Transcatheter Arterial Chemoinfusion according to Anticancer Agents and prognostic Factors in patients with Advanced Hepatocellular Carcinoma (TNM Stage IVa)
YONSEI MEDICAL JOURNAL 45-5 : 847-858 , 2004

Hepatitis B virus infection after renal transplantation in the presence of antibody to hepatitis B surface antigen immunity
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 19 : 847-853 , 2004

Analysis of gene expression profiles of hepatocellular carcinomas with regard to 18F-fluorodeoxyglucose uptake pattern on positron emission tomography
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 31-12 : 1621-1630 , 2004

¸¸¼º CÇü °£¿°¿¡¼­ Peginterferon-alpha ¿Í Ribavirin º´ÇÕ¿ä¹ý
´ëÇÑ°£ÇÐȸÁö 10-2 : 81-87 , 2004

Primary liver carcinoma of intermediate(Hepaticyte-Cholangiocyte) phenotype
JOURNAL OF HEPATOLOGY 40(2) : 298-304 , 2004

Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study
BRITISH MEDICAL JOURNAL 328 : 983-987 , 2004

µ¿½Ã Ç×¾Ï È­ÇÐ-¹æ»ç¼± ¿ä¹ý ÈÄ ±ÙÄ¡Àû °£ÀýÁ¦¼úÀ» ½ÃÇàÇÑ Á¦4±â °£¼¼Æ÷¾ÏÁ¾ 1¿¹
´ëÇÑ°£¾Ï¿¬±¸È¸Áö 5 : 22-26 , 2005

ÁøÇ༺ °£¼¼Æ÷¾ÏÁ¾¿¡¼­ µ¿½Ã Ç×¾ÏÈ­Çйæ»ç¼± Ä¡·á ÈÄ ¹ß»ýÇÑ ±Þ¼º °£±â´É ¾ÇÈ­ 2¿¹
´ëÇÑ°£¾Ï¿¬±¸È¸Áö 5 : 52-56 , 2005

Long-term clinical and histological outcomes in patients with spontaneous hepatitis B surface antigen seroclearance
JOURNAL OF HEPATOLOGY 42/2 : 188-194 , 2005

How to predict HCC development in patients with chronic B viral liver disease?
INTERVIROLOGY 48/1 : 23-28 , 2005

Evaluation of methods for monitoring drug resistance in chronic hepatitis B patients during lamivudine therapy based on mass spectrometry and reverse hybridization
ANTIVIRAL THERAPY 10-3 : 441-449 , 2005

Local radiotherapy as a complement to incomplete transcatheter arterial chemoembolization in locally advancedhepatocellular carcinoma
LIVER INTERNATIONAL 25 : 1189-1196 , 2005

Different Glucose Uptake and Glycolytic Mechanisms Between Hepatocellular Carcinoma and Intrahepatic Mass-Forming Cholangioca Cholangiocarcinoma with Increased 18F-FDG Uptake
JOURNAL OF NUCLEAR MEDICINE 46/10 : 1753-1759 , 2005

ÁøÇ༺ °£¼¼Æ÷¾Ï¿¡¼­ Chemoport SystemÀ» ÅëÇÑ ¹Ýº¹ÀûÀÎ °£µ¿¸Æ³» Ç׾Ͼ๰ÁÖÀÔ¿ä¹ýÀÇ È¿°ú
KOREAN JOURNAL OF HEPATOLOGY 11/3 : 268-274 , 2005

Long-term clinical outcome of large volume paracentesis with intravenous albumin in patients with spontaneous bacterial peritonitis: A randomized prospective study
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 20 : 1215-1222 , 2005

°£¼¼Æ÷¾ÏÀÇ Áø´Ü°ú Àç¹ßÆÇÁ¤¿¡¼­ PIVKA-¥±ÀÇ À¯¿ë¼º
´ëÇѳ»°úÇÐȸÁö 69/1 : 39-45 , 2005

Çѱ¹Àο¡¼­ Chemokine ¼ö¿ëü (CCR5) promoter À¯ÀüÀÚ ´ÙÇü¼º°ú BÇü°£¿° ¹ÙÀÌ·¯½º °¨¿° ÈÄ ÀÓ»ó °æ°ú¿ÍÀÇ »ó°ü¼º
´ëÇÑ°£ÇÐȸÁö 11/2 : 116-124 , 2005

Comparison of Rifaximin and Lactulose for the Treatment of Hepatic Encephalopathy: A Prospective Randomized Study
YONSEI MEDICAL JOURNAL 46/3 : 399-407 , 2005

Efficacy of repeated hepatic arterial infusion chemotherapy in advanced hepatocellular carcinoma with portal veintumor thromb thrombtumor thrombosis
KOREAN JOURNAL OF HEPATOLOGY 11-3 : 268-274 , 2005

°£¹®¸ÆÁ¾¾çÇ÷ÀüÁõÀ» µ¿¹ÝÇÑ °£¼¼Æ÷¾ÏÁ¾¿¡¼­ ¹Ýº¹ÀûÀÎ °£µ¿¸Æ ³» Ç׾Ͼ๰ÁÖÀÔ¿ä¹ýÀÇ È¿°ú
´ëÇÑ°£ÇÐȸÁö 11/3 : 268-274 , 2005

Usefulness of urine strip test in the rapid diagnosis of spontaneous bacterial peritonitis
LIVER INTERNATIONAL 25 : 1197-1201 , 2005

°£¼¼Æ÷¾ÏÁ¾ ȯÀÚ¿¡¼­ ÆóÀüÀÌ ½Ã ÆóÀýÁ¦¼úÀÇ ÀÓ»óÀû °á°ú
´ëÇÑ°£ÇÐȸÁö 11-4 : 350-358 , 2006

°£¼¼Æ÷¾ÏÁ¾ ȯÀÚ¿¡¼­ ÆóÀüÀÌ ½Ã ÆóÀýÁ¦¼úÀÇ ÀÓ»óÀû °á°ú
´ëÇÑ°£ÇÐȸÁö 11-4 : 350-358 , 2005

Hepatic stellate cells primed with cytokines upregulate inflammation in response to peptidoglycan or lipoteichoic acid
LABORATORY INVESTIGATION 86 : 676-686 , 2006

The clinical impact of early detection of the YMDD mutant on the outcomes of long-term lamivudine therapy in patients with chronic hepatitis B
ANTIVIRAL THERAPY 11 : 447-455 , 2006

HBeAg À½¼º ¸¸¼º BÇü°£¿°¹ÙÀÌ·¯½º °¨¿°ÀÇ ÀÚ¿¬°æ°ú: ÄÚȣƮ ¿¬±¸
´ëÇÑ°£ÇÐȸÁö 12/2 : 163-172 , 2006

°£¼¼Æ÷¾ÏÁ¾ÀÇ ¹æ»ç¼±Ä¡·á ½Ã ¹ß»ýÇÏ´Â °£µ¶¼º¿¡ ´ëÇÑ À§ÇèÀÎÀÚÀÇ Àç°íÂû
´ëÇÑ°£ÇÐȸÁö 12-3 : 420-428 , 2006

Long-term Clinical Outcome of Phase IIb Clinical Trial of Percutaneous Injection with Holmium-166/Chitosan Complex(Milican)fo Complex(Milican)for the Treatment of Small Hepatocellular Carcinoma
CLINICAL CANCER RESEARCH 12/1 : 543-548 , 2006

°£¼¼Æ÷¾Ï Ä¡·á¿¡¼­ ¼ö¼ú Àü °£µ¿¸Æ È­ÇлöÀü¼úÀÇ È¿°ú
´ëÇѳ»°úÇÐȸÁö 70/1 : 17-25 , 2006

Association of Genetic Variations in CCR5 and Its Ligand, RANTES With Clearance of Hepatitis B Virus in Korea
JOURNAL OF MEDICAL VIROLOGY 78/12 : 1564-1571 , 2006

Symptom Experience in Korean Patients with Liver Cirrhosis
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT 31/4 : 326-334 , 2006

Recent Variceal Bleeding: Doppler US Hepatic Vein Waveform in Assessmenet of Severity of Portal Hypertension and Vasoactive Drug Response
RADIOLOGY 240/2 : 574-580 , 2006

·§µå °£°æº¯ ¸ðµ¨¿¡¼­ ¹ßÇöµÇ´Â ´Ü¹éÁúÀÇ Å½»ö
´ëÇÑ°£ÇÐȸÁö 12/1 : 93-102 , 2006

Efficacy and Long-Term Follow Up of Combination Therapy with Interferon Alpha and Ribavirin for Chronic Hepatitis C in Korea
YONSEI MEDICAL JOURNAL 47/6 : 793-798 , 2006

Clinical outcome of renal transplantation in patients with positive pre-transplant hepatitis B surface antigen.
JOURNAL OF MEDICAL VIROLOGY 79-11 : 1655-1663 , 2007

Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B.
LIVER INTERNATIONAL 27-7 : 969-976 , 2007

Repetitive short-course hepatic arterial infusion chemotherapy with high-dose 5-fluorouracil and cisplatin in patients withad withadvanced hepatocellular carcinoma
CANCER 110/1 : 129-137 , 2007

MRP2 haplotypes confer differential susceptibility to toxic liver injury
PHARMACOGENETICS AND GENOMICS 17-6 : 403-415 , 2007

Evaluation of the prognostic value of Okuda, Cancer of the Liver Italian Program, and Japan Integrated Staging systems forhepatocellular carcinoma patients undergoing radiotherapy.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 67-4 : 1037-1042 , 2007

µ¿½Ã Ç×¾Ï È­ÇÐ-¹æ»ç¼± ¿ä¹ý ÈÄ ±ÙÄ¡Àû °£ÀýÁ¦¼úÀ» ½ÃÇàÇÑ ÇÏ´ëÁ¤¸Æ ħ½ÀÀÌ ÀÖ´Â ÁøÇ༺ °£¼¼Æ÷¾ÏÁ¾ 1¿¹
´ëÇÑ°£¾Ï¿¬±¸È¸Áö 7 : 77-81 , 2007

°£¼¼Æ÷¾ÏÀÇ Ç÷°üħ½À 2¿¹
´ëÇÑ°£¾Ï¿¬±¸È¸Áö 7 : 71-76 , 2007

ÇÏ´ëÁ¤¸Æ ħ½À ¶Ç´Â ½É¹æ Á¾¾çÇ÷ÀüÁõÀ» º¸ÀÌ´Â ÁøÇà °£¼¼Æ÷¾ÏÁ¾ÀÇ ÀÓ»ó Ư¡°ú Ä¡·á¿¡ µû¸¥ ¿¹ÈÄ
´ëÇÑ°£ÇÐȸÁö(Korean Journal of Hepatology) 13-3 : 387-395 , 2007

ÀÌÂ÷¼º ºñ±â´ÉÇ×ÁøÁõ¿¡¼­ ºÎºÐÀû ºñÀ嵿¸Æ»öÀü¼úÀÇ Àå±âÄ¡·á È¿°ú
´ëÇѳ»°úÇÐȸÁö 72-5 : 470-479 , 2007

Role of(18)F-Fluorodeoxyglucose positron Emission Tomography in detecting Extrahepatic Metastasisin pretreatment staging of hin pretreatment staging of hepatocellular carcinoma
ONCOLOGY 084-S1 : 1-7 , 2007

PIVKA-II is a useful tumor Marker for recurrent hepatocellular carcinoma after surgical resection
ONCOLOGY 72/S1 : 52-57 , 2007

radiation-induced hepatic toxicity after radiotherapy combined with chemotherapy forhepatocellular carcinoma
HEPATOLOGY RESEARCH 37 : 906-913 , 2007

Long-term outcome of chronic hepatitis B based on histological grade and stage
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 22-3 : 383-388 , 2007

Changes in Serum and Ascitic Monocyte Chemotactic Protein-1 (MCP-1) and IL-10 Levels in Cirrhotic Patients with SpontaneousBacterial Peritonitis
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH 27 : 227-230 , 2007

»ý°ËÀ¸·Î Áø´ÜµÈ °£¼¼Æ÷¾ÏÀÇ ½Ã»ó ÀüÀÌ
´ëÇѳ»°úÇÐȸÁö 73/3 : S880-S884 , 2007

Clinical experiences of PIVKA-II for the diagnosis of hepatocellular carcinoma in korea
KAN-TAN-SUI 54-4 : 533-540 , 2007

±¹¼Ò °£º´º¯ °¨º°¿¡¼­ ´Ü¹ß°í¼Ó½ºÇÉ¿¡ÄÚ ±â¹ý°ú ±ÕÇüÇ×Á¤»óÅ ¼¼Â÷¸¦ ÀÌ¿ëÇÑ °í¼Ó¿µ¿ª ±â¹ý°£ÀÇ ºñ±³
´ëÇÑÀÚ±â°ø¸íÀÇ°úÇÐȸÁö(Journal of the Korean Society of Magnetic Resonance in Medicine) 11 : 39-48 , 2007

What is the role of diagnostic laparoscopy in a gastroenterology unit?
JOURNAL OF GASTROENTEROLOGY 42 : 881-886 , 2007

¸¸¼º BÇü °£¿°È¯ÀÚ¿¡¼­ °£Åº·Âµµ ÃøÁ¤¿¡ ÀÇÇÑ °£¼¶À¯È­ÀÇ ºñħ½ÀÀû Æò°¡
´ëÇѳ»°úÇÐȸÁö 72/5 : 459-469 , 2007

Liver cancer in Korea
HEPATOLOGY RESEARCH 37S2 : S106-S109 , 2007

Entecavir Theraphy for up to 96 Weeks in Patients With HBeAg-Positive Chronic Heptitis B
GASTROENTEROLOGY 133 : 1437-1444 , 2007

Anti-hepatitis A virus seroprevalence among patients with chronic viral liver disease in Korea
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY 19/11 : 923-926 , 2007

Persistent hepatitis B viral replication affects recurrence of hepatocellular carcinoma after curative resection
Liver International 28/ : 393-401 , 2008

Pilot clinical trial of localized concurrent chemoradiation therapy for locally advanced hepatocellular carcinoma with portal vein thrombosis
Cancer 113/ : 995-1003 , 2008

MDM2 and p53 polymorphisms are associated with the development of hepatocellular carcinoma in patients with chronic hepatitis B virus infection
Carcinogenesis 29/ : 1192-1196 , 2008

Hepatic splenosis preoperatively diagnosed as hepatocellular carcinoma in a patient with chronic hepatitis B: A case report
Journal Of Korean Medical Science 23/ : 336-341 , 2008

µ¿½Ã Ç×¾ÏÈ­ÇÐ-¹æ»ç¼± ¿ä¹ý ÈÄ ±ÙÄ¡Àû °£ÀýÁ¦¼úÀ» ½ÃÇàÇÑ °£¼¼Æ÷¾Ï 1¿¹
´ëÇÑ°£¾Ï¿¬±¸È¸Áö 8/ : 98-101 , 2008

High prevalence of significant histology in asymptomatic chronic hepatitis B patients with genotype C and high serum HBV DNA levels
Journal Of Viral Hepatitis 15/ : 615-621 , 2008

Chemotherapy for advanced hepatocellular carcinoma
Journal Of Gastroenterology And Hepatology 23/ : 682-684 , 2008

´Ù¹ß¼º ÆóÀüÀ̸¦ µ¿¹ÝÇÑ ÁøÇ༺ °£¼¼Æ÷¾ÏÁ¾ ȯÀÚ¿¡¼­ Àü½ÅÇ×¾ÏÈ­Çпä¹ýÀÇ Ä¡·á¼ºÀû
´ëÇÑ°£ÇÐȸÁö 14/3 : 360-370 , 2008

Clinical Features and Treatment Outcomes of Upper Gastrointestinal Bleeding in Patients with Cirrhosis
Journal Of Korean Medical Science 23/4 : 635-643 , 2008

°£°æº¯Áõ Áã ¹«µ¨¿¡¼­ Ç÷û Hyaluronic acid¿Í °£¼¶À¯È­ÀÇ Á¤·«Àû ÃøÁ¤Ä¡ °£ÀÇ »ó°ü°ü°è
´ëÇÑ°£ÇÐȸÁö 14/2 : 159-167 , 2008

°£°æº¯Áõ ȯÀÚ¿¡¼­ °£Á¤¸Æ ¾Ð·ÂÂ÷¿Í °£°æº¯ÁõÀÇ ÀÓ»óº´±â, Á¤¸Æ·ù¹× º¹¼ö¿ÍÀÇ »ó°ü°ü°è
´ëÇÑ°£ÇÐȸÁö 14/2 : 150-158 , 2008

New diagnostic method for liver fibrosis and cirrhosis
Intervirology 51/ : 11-16 , 2008

Combination therapy of thymosin alpha-1 and lamivudine for HBeAg positive chronic hepatitis B: A prospective randomized, comparative pilot study
Journal Of Gastroenterology And Hepatology 23/ : 729-735 , 2008

Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with chronic hepatitis B
Journal Of Clinical Gastroenterology 42/ : 738-743 , 2008

¾çÃø ´ã°üÀ» ħ¹üÇÑ °£¹®ºÎ °£¼¼Æ÷¾ÏÀ» Åä¸ðÅ׶óÇǸ¦ ÀÌ¿ëÇÑ ÇÔ¾ÏÈ­ÇÐ-¹æ»ç¼± µ¿½Ã¿ä¹ýÀ¸·Î Ä¡·áÇÑ 1¿¹
´ëÇÑ°£¾Ï¿¬±¸È¸Áö 8/ : 102-105 , 2008

Chronic HBV infection with persistently normal ALT b. not to treat
Hepatology International 2/ : 185-189 , 2008

À½ÁÖ·Î ÀÎÇÑ »çȸ°æÁ¦Àû ºñ¿ë
°¡Á¤ÀÇÇÐȸÁö 29/3 : 201-212 , 2008

Prediction of microvascular invasion before curative resection of hepatocellular carcinoma
Journal Of Surgical Oncology 97/ : 246-252 , 2008

À½ÁÖ·Î ÀÎÇÑ »çȸ°æÁ¦Àû ºñ¿ë
°¡Á¤ÀÇÇÐȸÁö 29/3 : 201-212 , 2008

Natural history of hepatitis B virus-related cirrhotic patients hospitalized to control ascites
Journal Of Gastroenterology And Hepatology / : 1440-1746 , 2008

Fatal spontaneous bacterial peritonitis by Leclercia adecarboxylata in a patient with hepatocellular carcinoma
International Journal Of Clinical Practice 62/ : 1296-1298 , 2008

Clinical course of virologyic breakthrough after emergence of YMDD mutations in HBeAg-Positive chronic hepatitis B
Intervirology 51/ : 293-292 , 2008


º» ½Ã½ºÅÛÀÇ °­»çÁ¤º¸¿¡ ´ëÇÑ ¼ÒÀ¯±ÇÀº ÇØ´ç °­»ç¿¡°Ô ÀÖÀ¸¸ç, °­»ç¿¡ ´ëÇÑ Á¤º¸´Â °­»çÃßõ ¹× ¼Ò°³, ¼·¿Ü¸¸À» ¸ñÀûÀ¸·Î È°¿ëµË´Ï´Ù.

À̺ñ¾¾¿¡µà ¼­¿ï½Ã Á¾·Î±¸ ¿ÁÀÎ6±æ32 °í·Áºô¶ó B02È£    
´ëÇ¥ÀüÈ­ : 02-6263-0487   FAX : 02-3210-2609

Copyright ¨Ï À̺ñ¾¾¿¡µà. All rights reserved.
Contact Webmaster for more information. Mail to Webmaster